Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,192 stories indexed, page 113 of 154

🇯🇵Researchtohoku.ac.jp

Silicon-Compatible Nanocomposite Garnet Enables Better, Simpler Optical Isolators

Tohoku UniversityOriginal source
🇯🇵Researchtohoku.ac.jp

Rare-Earth-Free Zinc Oxide Achieves a First in Stress-to-Light Conversion

Tohoku UniversityOriginal source
🇯🇵Researchtohoku.ac.jp

Precise Synthesis of Incredibly Small and Effective Iridium Nanocluster Catalyst

Tohoku UniversityOriginal source
🇯🇵Researchtohoku.ac.jp

Mystery Solved! The Physics Behind Next-Generation Janus Semiconductors

Tohoku UniversityOriginal source
🇯🇵Researchtohoku.ac.jp

Making the Relaxation and Mental Benefits of Ikebana Accessible to All

Tohoku UniversityOriginal source
🇯🇵Researchtohoku.ac.jp

Healthy Lifespan Cut Short by Sex-Dependent Depressive Symptoms in Older Adults

Tohoku UniversityOriginal source
🇯🇵Researchtohoku.ac.jp

Finding Hidden Catalytic Knowledge from Literature Data

Tohoku UniversityOriginal source
🇯🇵Researchtohoku.ac.jp

Extending Cryo-Electron Microscopy Beyond Water

Tohoku UniversityOriginal source
🇯🇵Researchtohoku.ac.jp

Exciting New Strategy Enhances Oxygen Reduction in Zinc-Air Batteries

Tohoku UniversityOriginal source
🇯🇵Researchtohoku.ac.jp

Data-Driven Approach Quickly Screens for Durable, Efficient Catalysts

Tohoku UniversityOriginal source
🇦🇺Researchthermh.org.au

Welcoming the RMH’s new Chief Transformation Officer, Professor Peter Steel

The Royal Melbourne HospitalOriginal source
🇦🇺Researchthermh.org.au

Virtual Hospital Pilot program brings care home to more Victorians

The Royal Melbourne HospitalOriginal source
🇦🇺Researchthermh.org.au

Need an Electronic Medical Record fix? Call our Band of Builders

The Royal Melbourne HospitalOriginal source
🇦🇺Researchthermh.org.au

How a simple phone call helps support older persons with delirium

The Royal Melbourne HospitalOriginal source
🇦🇺Researchthermh.org.au

Global clinical trial reveals safest, most effective antibiotics for golden staph bloodstream infections

The Royal Melbourne HospitalOriginal source
🇦🇺Researchthermh.org.au

From a near-death experience to research breakthroughs – Lauren’s journey with porphyria

The Royal Melbourne HospitalOriginal source
🇦🇺Researchthermh.org.au

Celebrating the RMH staff recognised in 2026 King’s Birthday Honours

The Royal Melbourne HospitalOriginal source
🇦🇺Researchthermh.org.au

Celebrating 20 years of the Victorian Cancer Biobank

The Royal Melbourne HospitalOriginal source
🇦🇺Researchthermh.org.au

Across generations and cultures, RMH volunteers find common purpose

The Royal Melbourne HospitalOriginal source
🇦🇺Researchthermh.org.au

A love letter to the Royal Melbourne Hospital Intensive Care Unit by Peter McCormack

The Royal Melbourne HospitalOriginal source
🇺🇸Researchtexaschildrens.org

Recent Discoveries | Texas Children's

Texas Children's HospitalOriginal source
🇮🇱CDMOtevapharm.com

Teva Social Media Guidelines | Teva Pharmaceuticals

Teva Pharmaceutical IndustriesOriginal source
🇮🇱CDMOtevapharm.com

Q1 2026 Earnings - Press Kit & Media Assets

Teva Pharmaceutical IndustriesOriginal source
🇮🇱CDMOtevapharm.com

Neuroscience - Press Kit & Media Assets

Teva Pharmaceutical IndustriesOriginal source
🇮🇱CDMOtevapharm.com

Healthy Future Report - Press Kit & Media Assets

Teva Pharmaceutical IndustriesOriginal source
🇺🇸Industrytetrascience.com

TetraScience Launches Tetra Workflows to Automate Scientific Data Workflows at Scale

TetraScienceOriginal source
🇺🇸Industrytetrascience.com

TetraScience Launches Scientific AI Lighthouse Program with Takeda as Founding Partner

TetraScienceOriginal source
🇺🇸Industrytetrascience.com

November 19, 2024 TetraScience Launches First Universal Chromatography Dashboard for Enterprise-Scale Analytics in Life Sciences Learn more

TetraScienceOriginal source
🇺🇸Industrytetrascience.com

Accelerating the Scientific AI Revolution: TetraScience and Databricks Join Forces To Transform Scientific Research, Development, Manufacturing, and Quality Control in Life Sciences

TetraScienceOriginal source
🇺🇸Industrytetrascience.com

TetraScience Collaborates with NVIDIA to Industrialize the Production of Scientific AI Use Cases

TetraScienceOriginal source
🇺🇸Industrytetrascience.com

TetraScience and Bayer Expand Partnership to Advance Scientific Data Management

TetraScienceOriginal source
🇺🇸Industrytetrascience.com

TetraScience Appoints Matt Studney as Chief Customer Officer, Signaling Industry Shift Toward Platform-Based Scientific AI

TetraScienceOriginal source
🇺🇸Industrytetrascience.com

TetraScience Announces Collaboration with Thermo Fisher Scientific to Accelerate Scientific Data and AI Enablement Across the Laboratory

TetraScienceOriginal source
🇺🇸Industrytetrascience.com

TetraScience and Snowflake Partner to Accelerate Scientific AI Adoption Across Global Life Sciences

TetraScienceOriginal source
🇺🇸Industrytetrascience.com

TetraScience and Organon Collaborate to Modernize Quality Control Data Management

TetraScienceOriginal source
🇺🇸Industrytetrascience.com

TetraScience Collaborates with Microsoft To Advance Scientific AI at Scale

TetraScienceOriginal source
🇺🇸Industrytetrascience.com

April 22, 2026 Syngenta Deploys Tetra OS to Accelerate Scientific Discovery Through Industrial-Scale Data Automation Learn more

TetraScienceOriginal source
🇯🇵Industrytakeda.com

Statements | Takeda Pharmaceuticals

Takeda Oncology RSSOriginal source
🇯🇵Industrytakeda.com

Press Releases | Takeda Pharmaceuticals

Takeda Oncology RSSOriginal source
🇯🇵Industrytakeda.com

Corporate Materials and Profile | Takeda Pharmaceuticals

Takeda Oncology RSSOriginal source
🇯🇵Industrytaisho.co.jp

Taisho Pharmaceutical Holdings | Taisho Pharmaceutical Holdings

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Notice Regarding Counterfeit "Pabron Gold A" Cold Medicine

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Announcement of new structure|Taisho Pharmaceutical Holdings

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Launch of Nanozora® 30mg Autoinjector for S.C. Injection|Taisho Pharmaceutical Holdings

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Notification of the Approval of Home Self-injection Guidance and Management Fees and the Derestriction of the Dosing Period for NanozoraⓇ

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Notification of Approval to Manufacture and Market Nanozora® 30mg Autoinjectors for S.C. Injection in Japan|Taisho Pharmaceutical Holdings

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Launch of Nanozora® 30 mg Syringes for Subcutaneous Injection|Taisho Pharmaceutical Holdings

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Notification of Application for Approval to Manufacture and Market Rheumatoid Arthritis Therapy Nanozora® 30mg Autoinjectors for S.C. Injection in Japan|Taisho Pharmaceutical Holdings

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Notification of Approval to Manufacture and Market Nanozora® 30mg Syringes for S.C. Injection, a Therapy for Rheumatoid Arthritis, in Japan Japan's First NANOBODY® Therapeutic|Taisho Pharmaceutical Holdings

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Cetylpyridinium chloride hydrate (CPC) confirmed to have an action of inactivating SARS-CoV-2 variants

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Former All Blacks players Richard McCaw and Daniel Carter appointed Lipovitan Ambassadors|Taisho Pharmaceutical Holdings

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Data from Japan's First Phase II/III Clinical Trial of NANOBODY® Ozoralizumab for Rheumatoid Arthritis Presented at the 36th Annual Meeting of the Japanese Society for Clinical Rheumatology and Related Research

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Cetylpyridinium chloride hydrate (CPC) confirmed to have an action inactivating SARS-CoV-2

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Taisho Pharmaceutical appointed as Premium Global Partner of New Zealand Rugby|Taisho Pharmaceutical Holdings

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Taisho and Ancora Bio sign exclusive license agreement for the development, manufacturing, and commercialization of selective vasopressin V1b receptor antagonist, TS-121, worldwide

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Taisho Pharmaceutical appointed as Official Supplier of Rugby World Cup France 2023|Taisho Pharmaceutical Holdings

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Notification of Application for Approval to Manufacture and Market Anti-TNFα multivalent NANOBODY® compound (ozoralizumab) in Japan Japan's first NANOBODY® Therapeutic

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Group Companies Worldwide|Taisho Pharmaceutical

Taisho PharmaceuticalOriginal source
🇯🇵Industrytaisho.co.jp

Group Companies in Japan|Taisho Pharmaceutical

Taisho PharmaceuticalOriginal source